MMTLP Stock Lawsuit: How a Trading Halt Left Thousands of Investors Seeking Justice

Few stories in recent retail investing history have generated as much legal controversy as the MMTLP stock saga. What began as a corporate spinoff involving preferred shares of Meta Materials Inc. quickly spiraled into one of the most disputed regulatory events in modern securities law — leaving tens of thousands of ordinary investors locked out of their positions, unable to sell, and fighting for answers that regulators have been slow to provide.

Understanding the full legal picture behind MMTLP stock requires looking at who made the decisions, why investors believe those decisions were unlawful, and what legal remedies are currently being pursued.

What Was MMTLP Stock?

MMTLP stock — formally the preferred shares of Meta Materials Inc. — was created as part of a corporate restructuring involving the merger of Torchlight Energy Resources and Metamaterial Technologies. The preferred shares were designed to represent legacy oil and gas assets that would ultimately be spun off into a new private entity called Next Bridge Hydrocarbons (NBH).

In December 2022, as the spinoff approached completion and the MMTLP ticker was set to be delisted, the Financial Industry Regulatory Authority (FINRA) intervened. On December 9, 2022, FINRA issued a U3 trading halt — citing what it described as an “extraordinary event” creating settlement uncertainty. That halt prevented retail investors from selling their shares before delisting. When the ticker was removed on December 13, 2022, investors were left holding shares in a private company with no clear mechanism for trading, transferring, or monetizing them.

The Core Legal Grievances

The legal controversy surrounding MMTLP stock centers on several interconnected allegations:

Improper Use of Regulatory Authority Investors argue that FINRA’s U3 halt was improperly applied and that the regulatory body exceeded its authority under Rule 6440. Rather than protecting investors, critics contend the halt trapped them — preventing sales at a time when shares still had real market value.

Market Manipulation and Naked Short Selling A significant portion of investor litigation alleges that broker-dealers and market makers engaged in manipulative trading practices, including naked short selling — selling shares that haven’t been properly borrowed or located. Investors claim this artificially suppressed share prices and created phantom shares that distorted the market. Shareholders have sought blue sheet data from FINRA — detailed trading records and account holder information — that they believe could reveal evidence of stock spoofing, naked short selling, and fraud in MMTLP trading.

Regulatory Failures at Multiple Levels Regulatory bodies including FINRA, the SEC, and the DTCC have been accused of failing to address issues such as synthetic shares, settlement discrepancies, and failures to deliver — all of which worsened investor harm. Despite more than 56,000 investor complaints filed and two separate congressional inquiries initiated by Representatives Ralph Norman and Pete Sessions, many investors say meaningful regulatory action has never followed.

Who Is Being Sued — and By Whom?

The litigation landscape around MMTLP stock is extensive and ongoing. The primary defendant in much of the litigation is FINRA itself, with investors challenging the organization’s use of its authority to impose the December 2022 halt. Secondary defendants include major broker-dealers and clearing firms — including TD Ameritrade and Charles Schwab — as well as market makers accused of manipulative trading practices.

Active cases have been filed across California, Washington, Vermont, and Florida. Notable filings include Inter-Coastal Waterways vs. FINRA and TradeStation, and Scott Traudt vs. Ari Rubenstein, FINRA, and Schwab. A new shareholder lawsuit against FINRA was filed as recently as July 2025, confirming that legal efforts remain active. Separately, the SEC sued Meta Materials’ key executives, with the agency characterizing the corporate spinoff structure as fraudulent — further complicating the position of investors who never received their expected payout.

What Can Affected Investors Do?

If you held MMTLP stock at the time of the December 2022 trading halt, there are several actionable legal paths:

  • Join existing class action litigation — Multiple law firms have filed or are actively pursuing class actions on behalf of affected shareholders. Participating does not require serving as lead plaintiff, and many firms work on a contingency fee basis.
  • File regulatory complaints — Complaints submitted to the SEC, FINRA, and your state securities regulator build the official record and can support broader enforcement actions.
  • Consult a securities attorney — A lawyer specializing in investor rights can assess your individual loss, evaluate applicable claims, and advise on whether individual or collective legal action makes the most sense for your situation.
  • Monitor ongoing litigation — With numerous active cases across multiple jurisdictions, a favorable ruling in one case could meaningfully affect other pending claims.

The Bigger Legal Picture

The MMTLP stock controversy has grown far beyond one ticker symbol. It has become a defining flashpoint in a national conversation about the transparency of OTC markets, the accountability of self-regulatory organizations like FINRA, and whether the legal framework adequately protects retail investors when institutional actors make consequential decisions affecting their holdings.

Congressional inquiries have been launched, petitions have been addressed to the White House, and lawsuits continue advancing through courts across the country. The outcomes of these cases could carry lasting implications — reshaping how trading halts are applied, how naked short selling is policed, and what recourse retail investors have when the system fails them.

For the tens of thousands of investors still holding illiquid Next Bridge Hydrocarbons shares today, the legal fight over MMTLP stock is far from over. The courts may yet deliver what regulators have not.